|
Neoadjuvant endocrine therapy Clinical Trials
1 actively recruiting trial across 1 location
Washington D.C., District of Columbia1 trial
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
George Washington-Medical Faculty Associates
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.